Hamurcu Fatma, Alyar Saliha, Erden Busra Aksoy, Erden Yavuz
Department of Molecular Biology and Genetics, Faculty of Science, Bartin University, Bartin, Turkey.
Department of Chemistry, Faculty of Science, Karatekin University, Çankırı, Turkey.
J Biochem Mol Toxicol. 2025 Sep;39(9):e70485. doi: 10.1002/jbt.70485.
Schiff bases containing sulfonyl units are important compounds because of their potential biological properties in the therapeutical field. In this study, three novel ligands (L1, L2, and L3) containing the sulfonyl groups, a derivative of Schiff base, were synthesized, and their molecular structures were characterized by FT-IR, H-NMR, C NMR, and elemental analysis results. The antiproliferative activities of these Schiff base ligands were evaluated against human colon cancer (HT-29 and Caco-2) and mouse fibroblast (L929) cells by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) method. In addition, the antioxidant activities of these ligands were determined. Their potential activities against Peroxiredoxin 2 enzyme were assessed with molecular docking studies. When the spectral evaluation of the novel Schiff Base compounds (L1-3), the characteristic peaks and bands of target compounds were observed from H NMR, C NMR, and FT-IR results. The elemental analysis results supported the structures of the characterized compounds. All compounds' DPPH radical scavenging effect was similar to rutin at the highest applied concentration. According to molecular docking results, it was determined that hydrogen bond and steric interactions played a role in the interaction of the compounds and Peroxiredoxin 2 protein. It was observed that there was a parallelism between molecular docking results and antioxidant activity results. As a result of in silico and in vitro studies, it was found that L2 compound was the most effective compound with -60.083 MolDock Score and -61.079 total energy data. It was observed that hydrogen bonding and steric interactions played a role in the interaction of the compounds with the protein. Each compound showed cytotoxic effects against human colon cancer cells with increasing doses but not against healthy cells. These results support the hope that these compounds can be used for therapeutic purposes.
含磺酰基的席夫碱因其在治疗领域的潜在生物学特性而成为重要化合物。在本研究中,合成了三种含磺酰基的新型席夫碱衍生物配体(L1、L2和L3),并通过傅里叶变换红外光谱(FT-IR)、氢核磁共振(H-NMR)、碳核磁共振(C NMR)和元素分析结果对其分子结构进行了表征。采用3-(4,5-二甲基噻唑-2-基)-2,5-二苯基四氮唑溴盐(MTT)法评估了这些席夫碱配体对人结肠癌细胞(HT-29和Caco-2)和小鼠成纤维细胞(L929)的抗增殖活性。此外,还测定了这些配体的抗氧化活性。通过分子对接研究评估了它们对过氧化物还原酶2的潜在活性。对新型席夫碱化合物(L1-3)进行光谱评估时,从氢核磁共振、碳核磁共振和傅里叶变换红外光谱结果中观察到目标化合物的特征峰和谱带。元素分析结果支持了所表征化合物的结构。在最高应用浓度下,所有化合物的二苯基苦味酰基自由基(DPPH)清除效果与芦丁相似。根据分子对接结果,确定氢键和空间相互作用在化合物与过氧化物还原酶2蛋白的相互作用中起作用。观察到分子对接结果与抗氧化活性结果之间存在平行关系。计算机模拟和体外研究结果表明,L2化合物是最有效的化合物,其分子对接得分-60.083,总能量数据-61.079。观察到氢键和空间相互作用在化合物与蛋白质的相互作用中起作用。随着剂量增加,每种化合物对人结肠癌细胞均显示出细胞毒性作用,但对健康细胞无此作用。这些结果为这些化合物可用于治疗目的带来了希望。